Optimize your specialty product journey with our detailed channel strategy and implementation services
- Distribution Strategy
- Distribution implementation
- Gross to Net Financial Modeling
- Trade Marketing
Orphan drugs, cell & gene therapies and other specialty products have accounted for the majority of the U.S. Food & Drug Administration approvals for the past several years, and this trend is expected to continue.
That said, specialty launches tend to be more complicated than retail launches. Beyond State Licensing and HUB & Patient Services Strategy, it’s vital that you make the right decisions around your channel strategy, including selecting the right 3PL partner, speciality distributors, specialty pharmacy partners, integrating patient services solutions between the HUB and Specialty pharmacy, and modeling your finances and managing this complex process on an ongoing basis.
How We Can Help with Your Specialty Channel Strategy
At Two Labs, our Commercialization team handles the commercialization process from where you are to where you want to go. Whether you’re in the early stages of thinking about commercialization or you’re already in the thick of it and need help, we’ve got you covered. We prioritize saving you both time and money, taking out the guesswork and legwork needed to successfully bring a new specialty drug to the market.
When you work with us, you’ll work directly with a skilled account director to manage the entire launch process, as well as a group of commercialization experts who deliver their specific knowledge and experience to ensure you’re making the right decisions around your channel strategy and then making sure things are followed through properly.
For specialty drugs, we also provide several additional services, including pharmacy network selection, therapy management program design, specialty data recommendations, analytics strategy, and more.